• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无灌洗白内障手术:使围手术期医学治疗现代化,以改善手术效果和患者满意度。

Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction.

机构信息

Assil Eye Institute, Beverly Hills, California.

Vance Thompson Vision, Fargo, North Dakota.

出版信息

Curr Opin Ophthalmol. 2021 Jan;32 Suppl 1:S1-S12. doi: 10.1097/ICU.0000000000000708.

DOI:10.1097/ICU.0000000000000708
PMID:33273209
Abstract

PURPOSE OF REVIEW

Advances in pharmacology offer freedom from topical medical therapy without compromise of anti-inflammatory and antimicrobial coverage in the perioperative period. In this review, we describe the basis for dropless cataract surgery with the goal of improving outcomes and the patient experience.

RECENT FINDINGS

Phacoemulsification outcomes depend largely on surgeon skill but also on adherence to a complex multidrug regimen of perioperative anti-inflammatory and antimicrobial therapy to prevent sight-threatening complications such as cystoid macular edema or endophthalmitis. Successful administration of this regimen can be limited by noncompliance, difficulty administering eye drops, bioavailability, and side effects, among others. The recent development of sustained-release formulations of dexamethasone - one an intracanalicular insert and the other an intraocular suspension - can provide sustained tapering doses of dexamethasone while reducing or eliminating the need for anti-inflammatory eye drop therapy. Similarly, mounting evidence compellingly demonstrates that intracameral antibiotic use intraoperatively is at least as effective as topical antibiotics in preventing endophthalmitis.

SUMMARY

Sustained-release dexamethasone coupled with intracameral antibiotics at the time of phacoemulsification can provide antimicrobial and anti-inflammatory prophylaxis without the need for topical eye drop medications. This approach has the potential to improve compliance with therapy, visual acuity outcomes, and the overall patient experience.

摘要

目的综述:药理学的进步使我们在围手术期能够避免局部药物治疗,而不会影响抗炎和抗菌的覆盖范围。在本次综述中,我们将介绍无滴剂白内障手术的基础,旨在改善手术结果和患者体验。

最近发现:超声乳化手术的结果在很大程度上取决于外科医生的技术水平,但也取决于是否遵守复杂的多药物围手术期抗炎和抗菌治疗方案,以预防威胁视力的并发症,如黄斑囊样水肿或眼内炎。由于不遵医嘱、滴眼困难、生物利用度和副作用等原因,这种方案的成功实施可能会受到限制。最近,地塞米松的缓释制剂得到了发展,一种是经巩膜睫状体沟给药的植入剂,另一种是眼内悬浮剂,可以提供持续递减剂量的地塞米松,同时减少或消除对抗炎滴眼剂治疗的需求。同样,越来越多的证据有力地证明,在白内障超声乳化术中使用眼内抗生素与局部使用抗生素预防眼内炎同样有效。

总结:在白内障超声乳化术中联合使用缓释地塞米松和眼内抗生素,可以提供抗菌和抗炎预防,而无需局部滴眼药物。这种方法有可能提高治疗的依从性、视力结果和整体患者体验。

相似文献

1
Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction.无灌洗白内障手术:使围手术期医学治疗现代化,以改善手术效果和患者满意度。
Curr Opin Ophthalmol. 2021 Jan;32 Suppl 1:S1-S12. doi: 10.1097/ICU.0000000000000708.
2
Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery.白内障手术后预防眼内炎症和黄斑水肿的单次眼周皮质类固醇储库与术后皮质类固醇眼药水的比较。
J Cataract Refract Surg. 2011 Sep;37(9):1589-97. doi: 10.1016/j.jcrs.2011.03.049.
3
Prednisolone versus dexamethasone for prevention of pseudophakic cystoid macular edema.泼尼松龙与地塞米松预防后发性白内障囊样黄斑水肿的比较。
Can J Ophthalmol. 2018 Apr;53(2):131-134. doi: 10.1016/j.jcjo.2017.08.012.
4
Dropless Cataract Surgery: An Overview.无灌注白内障手术概述
Curr Pharm Des. 2017;23(4):558-564. doi: 10.2174/1381612822666161129150628.
5
Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide.局部地塞米松滴眼液在单纯白内障手术后预防眼内炎症和囊样黄斑水肿的疗效,无论是否在围手术期单次注射曲安奈德前Tenon 囊下注射。
Cutan Ocul Toxicol. 2022 Dec;41(4):310-317. doi: 10.1080/15569527.2022.2136193. Epub 2022 Oct 29.
6
A Randomized, Prospective, Observer-Masked Study Comparing Dropless Treatment Regimen Using Intracanalicular Dexamethasone Insert, Intracameral Ketorolac, and Intracameral Moxifloxacin versus Conventional Topical Therapy to Control Postoperative Pain and Inflammation in Cataract Surgery.一项随机、前瞻性、观察者盲法研究,比较使用泪小管内插入地塞米松、前房内注射酮咯酸和前房内注射莫西沙星的无滴剂治疗方案与传统局部治疗方案对白内障手术术后疼痛和炎症的控制效果。
Clin Ophthalmol. 2023 Aug 15;17:2349-2356. doi: 10.2147/OPTH.S422502. eCollection 2023.
7
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.辅助性类固醇疗法与单纯抗生素疗法治疗眼内手术后急性眼内炎的对比
Cochrane Database Syst Rev. 2017 Feb 22;2(2):CD012131. doi: 10.1002/14651858.CD012131.pub2.
8
Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.白内障手术中未稀释前房内注射莫西沙星且术后不使用局部抗生素的安全性
Int Ophthalmol. 2016 Aug;36(4):493-8. doi: 10.1007/s10792-015-0151-x. Epub 2015 Nov 14.
9
Transzonular moxifloxacin and dexamethasone delivery in phacoemulsification: A novel dropless regimen.超声乳化术中经巩膜睫状体给药莫西沙星和地塞米松:一种新的无滴剂方案。
Indian J Ophthalmol. 2024 Aug 1;72(8):1147-1149. doi: 10.4103/IJO.IJO_2697_23. Epub 2024 May 20.
10
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.北加州某眼科机构施行眼内局部应用抗生素后,术后眼内炎发生率降低。
J Cataract Refract Surg. 2013 Jan;39(1):8-14. doi: 10.1016/j.jcrs.2012.07.031. Epub 2012 Oct 2.

引用本文的文献

1
The future of cataract surgery.白内障手术的未来。
Eye (Lond). 2025 Jun;39(8):1451-1456. doi: 10.1038/s41433-025-03745-x. Epub 2025 Mar 13.
2
Biocompatibility of light responsive materials prepared for accommodative intraocular lenses manufacturing.用于制造可调节人工晶状体的光响应材料的生物相容性。
Int J Ophthalmol. 2024 Dec 18;17(12):2167-2176. doi: 10.18240/ijo.2024.12.03. eCollection 2024.
3
Adopting Interventional Glaucoma Via Sustained-Release Therapies: The Wide-Ranging Impact of Procedural Pharmaceuticals in Ophthalmology.
通过缓释疗法采用介入性青光眼治疗:眼科手术用药物的广泛影响。
Ophthalmol Ther. 2024 Nov;13(11):2825-2838. doi: 10.1007/s40123-024-01041-7. Epub 2024 Oct 10.
4
Efficacy and safety of 'dropless vitrectomy surgery' and comparison of outcomes to standard of care topical therapy.“无灌注玻璃体切除术”的疗效与安全性以及与标准护理局部治疗的结果比较。
Front Ophthalmol (Lausanne). 2023 Jul 28;3:1215968. doi: 10.3389/fopht.2023.1215968. eCollection 2023.
5
Early Real-World Patient and Staff Experience with an Intracanalicular Dexamethasone Insert.早期实际应用泪小管地塞米松植入物的患者及医护人员体验
Clin Ophthalmol. 2024 May 19;18:1391-1401. doi: 10.2147/OPTH.S448973. eCollection 2024.
6
Combinative approach of transzonular triamcinolone-moxifloxacin and perioperative drops to minimize postoperative complications of cataract surgery.经巩膜环扎联合曲安奈德-莫西沙星及围手术期滴眼液以减少白内障手术术后并发症的方法
Int J Ophthalmol. 2024 May 18;17(5):845-851. doi: 10.18240/ijo.2024.05.08. eCollection 2024.
7
New Approaches to Overcoming Antimicrobial Resistance in Endophthalmitis.克服眼内炎抗菌耐药性的新方法
Pharmaceuticals (Basel). 2024 Mar 1;17(3):321. doi: 10.3390/ph17030321.
8
A Preservative-Free Approach - Effects on Dry Eye Signs and Symptoms After Cataract Surgery.一种无防腐剂方法——对白内障手术后干眼体征和症状的影响。
Clin Ophthalmol. 2024 Feb 26;18:591-604. doi: 10.2147/OPTH.S446804. eCollection 2024.
9
DEXTENZA versus Topical Steroid or Antihistamine Therapy for Treatment of Allergic Conjunctivitis.DEXENZA与局部用类固醇或抗组胺药治疗变应性结膜炎的对比研究
Clin Ophthalmol. 2024 Feb 14;18:473-480. doi: 10.2147/OPTH.S440840. eCollection 2024.
10
Modeling Cataract Surgery in Mice.小鼠白内障手术建模。
J Vis Exp. 2023 Dec 1(202). doi: 10.3791/66050.